Loading clinical trials...
Loading clinical trials...
Succinylcholine is currently the only depolarizing neuromuscular blocker widely used in anesthesia induction and is the drug of choice for rapid sequential anesthesia induction. However, with succinyl...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Yangzhou University
NCT05909696 · Succinylcholine, Myofibrillation
NCT03334786 · Amyotrophic Lateral Sclerosis, Fasciculation
NCT02502032 · Fasciculations
NCT02481193 · Fasciculation
NCT01902641 · Intubating Conditions, Fasciculations, and more
the Affiliated Hospital of Yangzhou University
Yangzhou, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions